Kedrion Biopharma Receives FDA Approval for QIVIGY for Primary Humoral Immunodeficiency

Kedrion Biopharma announced FDA approval for QIVIGY (Immune Globulin 10% IV) for treating adults with primary humoral immunodeficiency (PI). QIVIGY, a...